The Trip Report
En podcast af Beckley Waves - Torsdage
Kategorier:
36 Episoder
-
#34 Shamil Chandaria: Computational Neuroscience and Human Flourishing
Udgivet: 17.10.2024 -
#33 Rock Feilding-Mellen: Building the Future of the Psychedelic Field
Udgivet: 3.10.2024 -
#32 Rachelle Sampson & Bennet Zelner: The Connected Leadership Study
Udgivet: 19.9.2024 -
Ep #31 Rebecca Kronman: Psychedelics & Parenting
Udgivet: 5.9.2024 -
Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy
Udgivet: 22.8.2024 -
Special Dispatch: FDA Rejects Lykos’ MDMA Assisted Therapy Application
Udgivet: 13.8.2024 -
#29 Dr. Selma Holden MD: All Eyes on the FDA
Udgivet: 8.8.2024 -
#28 East Forest: Music for Mushrooms
Udgivet: 25.7.2024 -
#27 Joanna Kempner: Psychedelic Outlaws
Udgivet: 11.7.2024 -
#26 Brandon Kapelow: ‘An Act of Service’- A Journey Through PTSD and Ketamine Therapy
Udgivet: 27.6.2024 -
#25 Christof Koch: Exploring Consciousness and Perception
Udgivet: 13.6.2024 -
#24 Manesh Girn Ph.D. - Exploring the Psychedelic Brain and Human Potential
Udgivet: 30.5.2024 -
#23 Dennis Walker: The Court Jester of Psychedelics
Udgivet: 16.5.2024 -
#22 Bruce Damer: Catalyzing Scientific and Creative Breakthroughs
Udgivet: 2.5.2024 -
#21: Pedro Teixeira, Ph.D. - Psychedelics and Health Behavior Change
Udgivet: 18.4.2024 -
#20: Jackie von Salm, Ph.D. - Natural Products & Novel Therapies
Udgivet: 4.4.2024 -
#19 Beckley Academy: Charting the Course for Psychedelic-Assisted Therapy
Udgivet: 21.3.2024 -
#18 Rick Doblin: The Path to MDMA Approval and Beyond
Udgivet: 7.3.2024 -
#17: Marcus Capone: Psychedelic Access for Veterans
Udgivet: 22.2.2024 -
#16: Greg Kubin: The Varieties of Mental Health Innovation
Udgivet: 8.2.2024
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com
